incb081776
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 24, 2018 (NCT03522142)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
MERTK inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06308913 | Early Phase 1 (Phase 1) | Sep 18, 2024 | National Cancer Institute (NCI), National Institute of Dental and Craniofacial Research (NIDCR), University of Wisconsin |
| NCT03522142 | Phase 1 | May 24, 2018 | Incyte |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Incyte | For profit | 1 | 1 | 1 | 2018 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2024 |
| National Institute of Dental and Craniofacial Research (NIDCR) | Government | 1 | 0 | 1 | 2024 |
| University of Wisconsin | Academic/Hospital | 1 | 1 | 1 | 2024 |
4 organizations
Page 1 / 1